Travere Therapeutics, Inc. (TVTX)
USD 16.86
(-1.63%)
USD 16.86
(-1.63%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 404.78 Million USD | -0.66% |
| 2022 | 407.48 Million USD | 55.54% |
| 2021 | 261.98 Million USD | 21.66% |
| 2020 | 215.33 Million USD | 5.11% |
| 2019 | 204.86 Million USD | -5.83% |
| 2018 | 217.54 Million USD | 382.61% |
| 2017 | 45.07 Million USD | 1.47% |
| 2016 | 44.42 Million USD | 1.18% |
| 2015 | 43.9 Million USD | -47.59% |
| 2014 | 83.77 Million USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 884.76 Thousand USD | 3439.06% |
| 2011 | 25 Thousand USD | 0.0% |
| 2010 | 25 Thousand USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 4167.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 403.22 Million USD | -0.2% |
| 2024 Q1 | 404.01 Million USD | -0.19% |
| 2024 Q3 | 402.43 Million USD | -0.2% |
| 2023 Q4 | 404.78 Million USD | -0.17% |
| 2023 Q1 | 406.84 Million USD | -0.16% |
| 2023 FY | 404.78 Million USD | -0.66% |
| 2023 Q3 | 405.47 Million USD | -0.17% |
| 2023 Q2 | 406.17 Million USD | -0.17% |
| 2022 Q3 | 407.61 Million USD | -0.14% |
| 2022 Q1 | 408.78 Million USD | 56.03% |
| 2022 Q2 | 408.17 Million USD | -0.15% |
| 2022 Q4 | 407.48 Million USD | -0.03% |
| 2022 FY | 407.48 Million USD | 55.54% |
| 2021 Q2 | 220.86 Million USD | 1.28% |
| 2021 FY | 261.98 Million USD | 21.66% |
| 2021 Q1 | 218.07 Million USD | 1.27% |
| 2021 Q3 | 223.69 Million USD | 1.28% |
| 2021 Q4 | 261.98 Million USD | 17.12% |
| 2020 Q4 | 215.33 Million USD | 1.26% |
| 2020 Q1 | 207.41 Million USD | 1.25% |
| 2020 FY | 215.33 Million USD | 5.11% |
| 2020 Q2 | 210 Million USD | 1.25% |
| 2020 Q3 | 212.65 Million USD | 1.26% |
| 2019 Q3 | 202.35 Million USD | 1.23% |
| 2019 FY | 204.86 Million USD | -5.83% |
| 2019 Q1 | 220 Million USD | 1.13% |
| 2019 Q2 | 199.89 Million USD | -9.14% |
| 2019 Q4 | 204.86 Million USD | 1.24% |
| 2018 Q1 | 45.23 Million USD | 0.36% |
| 2018 Q4 | 217.54 Million USD | 1.12% |
| 2018 Q3 | 215.13 Million USD | 373.84% |
| 2018 FY | 217.54 Million USD | 382.61% |
| 2018 Q2 | 45.4 Million USD | 0.36% |
| 2017 Q3 | 44.91 Million USD | 0.37% |
| 2017 Q1 | 44.58 Million USD | 0.36% |
| 2017 Q2 | 44.74 Million USD | 0.37% |
| 2017 FY | 45.07 Million USD | 1.47% |
| 2017 Q4 | 45.07 Million USD | 0.37% |
| 2016 Q3 | 44.25 Million USD | 0.37% |
| 2016 FY | 44.42 Million USD | 1.18% |
| 2016 Q2 | 44.09 Million USD | 0.37% |
| 2016 Q4 | 44.42 Million USD | 0.37% |
| 2016 Q1 | 43.92 Million USD | 0.06% |
| 2015 FY | 43.9 Million USD | -47.59% |
| 2015 Q1 | 84.24 Million USD | 0.56% |
| 2015 Q2 | 84.71 Million USD | 0.56% |
| 2015 Q3 | 43.74 Million USD | -48.36% |
| 2015 Q4 | 43.9 Million USD | 0.35% |
| 2014 Q4 | 83.77 Million USD | 0.58% |
| 2014 FY | 83.77 Million USD | 0.0% |
| 2014 Q3 | 83.29 Million USD | 0.58% |
| 2014 Q2 | 82.81 Million USD | 164.72% |
| 2014 Q1 | 31.28 Million USD | 0.0% |
| 2013 Q3 | 10 Thousand USD | 0.0% |
| 2013 Q1 | 10 Thousand USD | -60.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q2 | 10 Thousand USD | 0.0% |
| 2012 Q4 | 25 Thousand USD | 0.0% |
| 2012 FY | 884.76 Thousand USD | 3439.06% |
| 2012 Q1 | 25 Thousand USD | 0.0% |
| 2012 Q2 | 25 Thousand USD | 0.0% |
| 2012 Q3 | 25 Thousand USD | 0.0% |
| 2011 Q2 | 25 Thousand USD | 0.0% |
| 2011 Q1 | 25 Thousand USD | 0.0% |
| 2011 FY | 25 Thousand USD | 0.0% |
| 2011 Q4 | 25 Thousand USD | 0.0% |
| 2011 Q3 | 25 Thousand USD | 0.0% |
| 2010 FY | 25 Thousand USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | 19.79 Thousand USD | 0.0% |
| 2010 Q3 | 22.91 Thousand USD | 15.79% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | 13.54 Thousand USD | 30.0% |
| 2009 Q3 | 10.41 Thousand USD | 42.86% |
| 2009 Q2 | 7293.00 USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | 4167.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -76.429% |
| IO Biotech, Inc. | 2.49 Million USD | -16130.313% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -189051.402% |
| Organovo Holdings, Inc. | 1.39 Million USD | -28937.59% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -828187.293% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -246769.187% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4024.977% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -5662.87% |
| Savara Inc. | 26.73 Million USD | -1413.89% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -59868.0% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1516.42% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1838.228% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4676240.111% |
| Soligenix, Inc. | 3.49 Million USD | -11483.258% |
| Aptose Biosciences Inc. | 1 Million USD | -39985.323% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1931.946% |
| Century Therapeutics, Inc. | 48.17 Million USD | -740.306% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -867.388% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1194.563% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -117.191% |
| Kura Oncology, Inc. | 17.2 Million USD | -2253.395% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -295515.976% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -337.922% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -13994.15% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2796.694% |
| Autolus Therapeutics plc | 52.96 Million USD | -664.219% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -7320.422% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -7301.426% |
| GRI Bio, Inc. | 14 Thousand USD | -2891214.286% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3158.081% |
| IGM Biosciences, Inc. | 40.5 Million USD | -899.319% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -125.346% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6752.547% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -48855.305% |
| Opthea Limited | 200.62 Million USD | -101.758% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -594.539% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -599.447% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3459.479% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -6465.839% |
| Surrozen, Inc. | 3.37 Million USD | -11879.402% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -12811.363% |
| Ovid Therapeutics Inc. | 46 Million USD | -779.932% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -200.946% |
| Acelyrin, Inc. | 1.19 Million USD | -33801.508% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -378.536% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -193558.023% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1239.635% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -552.089% |
| ADMA Biologics, Inc. | 141.41 Million USD | -186.232% |
| PureTech Health plc | 25.51 Million USD | -1486.642% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -127190.566% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -23070.235% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3019.482% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -378.05% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -163780.162% |
| ChromaDex Corporation | 3.27 Million USD | -12252.273% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -64977.5% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -113.107% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -288.535% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2620.323% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1222.219% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -264.907% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -962.314% |
| Seer, Inc. | 28.25 Million USD | -1332.407% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -6503.328% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -6311.912% |
| Gritstone bio, Inc. | 104.77 Million USD | -286.336% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14429.218% |
| Avid Bioservices, Inc. | 207.83 Million USD | -94.763% |
| Insmed Incorporated | 1.2 Billion USD | 66.38% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -7693.3% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -10271.099% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -290.96% |
| MediWound Ltd. | 6.71 Million USD | -5931.65% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -299.258% |
| Fortress Biotech, Inc. | 88.59 Million USD | -356.908% |
| OmniAb, Inc. | 25.56 Million USD | -1483.6% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -89.208% |
| Zai Lab Limited | 15.15 Million USD | -2571.665% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 15.394% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1175.633% |
| Veracyte, Inc. | 12.63 Million USD | -3104.941% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -7396.0% |
| FibroGen, Inc. | 170.45 Million USD | -137.473% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -19800.895% |
| ContextLogic Inc. | 6 Million USD | -6646.4% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -256092.405% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6071.429% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 93.017% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -493.264% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1093910.811% |
| ImmuCell Corporation | 11.96 Million USD | -3281.851% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 75.877% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5432.103% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14429.218% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -798.063% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -837.673% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -794.827% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -739.296% |
| Vaxxinity, Inc. | 15.16 Million USD | -2568.671% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 52.306% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -39298.948% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2851696.534% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1805.852% |
| Senti Biosciences, Inc. | 37.66 Million USD | -974.667% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -249278.685% |
| Apollomics, Inc. | 4.66 Million USD | -8584.488% |
| 89bio, Inc. | 27.1 Million USD | -1393.227% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -251.463% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -89738.006% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -5761.338% |
| Ardelyx, Inc. | 55.98 Million USD | -623.061% |
| Pluri Inc. | 29.61 Million USD | -1266.959% |
| Prothena Corporation plc | 11.83 Million USD | -3320.228% |
| Pulmatrix, Inc. | 8.75 Million USD | -4522.933% |
| Celularity Inc. | 65.41 Million USD | -518.775% |
| MeiraGTx Holdings plc | 89.26 Million USD | -353.468% |
| Omeros Corporation | 338.28 Million USD | -19.659% |
| Ainos, Inc. | 5.96 Million USD | -6687.628% |
| Humacyte, Inc. | 58.1 Million USD | -596.63% |
| Mesoblast Limited | 118.92 Million USD | -240.375% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -21744.792% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -8199.856% |
| Blueprint Medicines Corporation | 774.12 Million USD | 47.711% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -7966.64% |
| Summit Therapeutics Inc. | 106.09 Million USD | -281.515% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -554.8% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -250.93% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1183.073% |
| Cytokinetics, Incorporated | 755.77 Million USD | 46.441% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2924.387% |
| Nutriband Inc. | 241.28 Thousand USD | -167661.775% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -7304.134% |
| Roivant Sciences Ltd. | 499.74 Million USD | 19.003% |
| Evogene Ltd. | 1.13 Million USD | -35469.772% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -32916.639% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -733669.6% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 76.734% |
| BioLineRx Ltd. | 11.59 Million USD | -3392.227% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2356.81% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -18993.585% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -314.708% |
| MediciNova, Inc. | 215.92 Thousand USD | -187364.224% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -16123.808% |
| MiMedx Group, Inc. | 48.09 Million USD | -741.564% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 2.468% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -11175.32% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -24657.431% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -495472.968% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4318.557% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2659.076% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1376.506% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3202.203% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3136.718% |
| Allakos Inc. | 41.46 Million USD | -876.206% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3640.726% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -267968.874% |
| BioAtla, Inc. | 2.46 Million USD | -16354.634% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -325.546% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7198.666% |
| Precigen, Inc. | 7.09 Million USD | -5603.593% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -225.258% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2037.981% |
| Incyte Corporation | 38.28 Million USD | -957.236% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -837.716% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3534.261% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -69.627% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1454.291% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -115883.954% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -123879.381% |
| UroGen Pharma Ltd. | 100.21 Million USD | -303.92% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -121.497% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -116774.072% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -132616.066% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -5822.224% |
| Chimerix, Inc. | 2.14 Million USD | -18779.851% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1038.464% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -234322.29% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1426.738% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -861142.553% |
| OncoCyte Corporation | 2.86 Million USD | -14008.888% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -31056.02% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1895843.794% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -268762.999% |
| Purple Biotech Ltd. | 351 Thousand USD | -115223.077% |
| NextCure, Inc. | 6.6 Million USD | -6028.448% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -313.492% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -7638.176% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -76.614% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -41716.529% |
| NLS Pharmaceutics AG | 1.63 Million USD | -24676.434% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -44.239% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -14387.616% |
| Daré Bioscience, Inc. | 5.31 Million USD | -7511.376% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -71543.186% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -800.4% |
| BeiGene, Ltd. | 930.18 Million USD | 56.483% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2504.369% |
| Alector, Inc. | 38.91 Million USD | -940.095% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -35376.249% |
| Erasca, Inc. | 55.85 Million USD | -624.653% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1969.765% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1483.91% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -103160.698% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 64.301% |
| Histogen Inc. | 4.62 Million USD | -8657.767% |
| Fortress Biotech, Inc. | 88.59 Million USD | -356.908% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4008.648% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -540.816% |
| Galecto, Inc. | 249 Thousand USD | -162463.855% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 37.23% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -191.149% |
| Molecular Templates, Inc. | 12.23 Million USD | -3209.763% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1597.092% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -9453.552% |
| Amarin Corporation plc | 8.73 Million USD | -4532.986% |
| TG Therapeutics, Inc. | 110.79 Million USD | -265.345% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -7400.167% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -15823.839% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2047.054% |
| Onconetix, Inc. | 9.88 Million USD | -3994.612% |
| MacroGenics, Inc. | 33.97 Million USD | -1091.558% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -28426.004% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -1714.616% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -92.625% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3594.97% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1894.698% |
| SciSparc Ltd. | 76 Thousand USD | -532510.526% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -393.538% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -122934.65% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1500.063% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -96.577% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -657.087% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 84.911% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5186.183% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -642414.286% |
| 2seventy bio, Inc. | 256.67 Million USD | -57.704% |
| Clene Inc. | 32.16 Million USD | -1158.618% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -18341.185% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -198410.134% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -4541.486% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -2436.717% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2253.806% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1405.837% |
| Entera Bio Ltd. | 390 Thousand USD | -103690.769% |
| Trevena, Inc. | 35.23 Million USD | -1048.877% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1504.058% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1372.745% |
| INmune Bio, Inc. | 10.43 Million USD | -3778.356% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -84011.835% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6131.281% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -987178.049% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1399.755% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -80710.856% |
| Jaguar Health, Inc. | 35.86 Million USD | -1028.79% |
| Clearside Biomedical, Inc. | 43 Million USD | -841.336% |
| NexImmune, Inc. | 68.8 Thousand USD | -588171.883% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -86950.323% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -32964.483% |
| Kronos Bio, Inc. | 28.27 Million USD | -1331.749% |
| Innoviva, Inc. | 449.07 Million USD | 9.863% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 15.818% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 85.024% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1901.998% |
| Verastem, Inc. | 41.55 Million USD | -874.045% |
| ProKidney Corp. | 4.41 Million USD | -9072.536% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -25931.125% |
| Imunon, Inc. | 1.62 Million USD | -24814.17% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -32025.714% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2389.272% |
| ImmunityBio, Inc. | 883.67 Million USD | 54.193% |
| Korro Bio, Inc. | 33.2 Million USD | -1118.972% |
| Kineta, Inc. | 1.31 Million USD | -30635.308% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -11279.927% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7112.632% |
| GT Biopharma, Inc. | 58 Thousand USD | -697803.448% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2702.437% |
| Celularity Inc. | 65.41 Million USD | -518.775% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -682.524% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -1544.06% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -470.311% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -266.792% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -105587.728% |
| Kodiak Sciences Inc. | 181.63 Million USD | -122.859% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -288.856% |
| Annexon, Inc. | 31.35 Million USD | -1190.971% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -439.453% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -17183.689% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -5752.017% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2822.628% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 72.152% |
| Vor Biopharma Inc. | 35.66 Million USD | -1035.121% |
| Eyenovia, Inc. | 16.1 Million USD | -2412.975% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -101096.0% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -263.068% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -779.22% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1160.303% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -40994.822% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -607.602% |
| Immunocore Holdings plc | 84.03 Million USD | -381.702% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -940.041% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -463.711% |
| Alkermes plc | 290.73 Million USD | -39.23% |
| Arcellx, Inc. | 97.62 Million USD | -314.631% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -16415.082% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -784.329% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -622644.615% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -12949.13% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -31999.525% |
| Moolec Science SA | 2.64 Million USD | -15202.071% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3831.469% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -371.232% |
| Mereo BioPharma Group plc | 5.95 Million USD | -6700.806% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -789.44% |
| Royalty Pharma plc | 6.13 Billion USD | 93.402% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -16751.957% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -24196.759% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -351110.37% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1096.524% |
| Humacyte, Inc. | 58.1 Million USD | -596.63% |
| Structure Therapeutics Inc. | 5.45 Million USD | -7323.142% |
| NLS Pharmaceutics AG | 1.63 Million USD | -24676.434% |
| Genelux Corporation | 2.51 Million USD | -15969.234% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -503813.953% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2581.577% |
| Notable Labs, Ltd. | 2.04 Million USD | -19655.198% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -134507.634% |
| Mustang Bio, Inc. | 2.49 Million USD | -16104.323% |
| Immunovant, Inc. | 138 Thousand USD | -293221.739% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -24707.121% |
| Vericel Corporation | 88.14 Million USD | -359.236% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 73.001% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -1285.108% |
| Orgenesis Inc. | 22.62 Million USD | -1689.417% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -8682.469% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -199300.985% |
| GH Research PLC | 343 Thousand USD | -117912.828% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1859.169% |
| PepGen Inc. | 20.1 Million USD | -1913.45% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -70419.861% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -400676.238% |
| Belite Bio, Inc | 886 Thousand USD | -45586.682% |
| Pharming Group N.V. | 171.54 Million USD | -135.964% |
| XOMA Corporation | 124.45 Million USD | -225.258% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -41501.644% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -68.929% |
| Xencor, Inc. | 83.43 Million USD | -385.155% |
| Replimune Group, Inc. | 75.86 Million USD | -433.53% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1797.633% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4204.381% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -12494.4% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2305.134% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -16647.373% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -31999.525% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -358115.929% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -39123.256% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -12713.675% |
| scPharmaceuticals Inc. | 40.26 Million USD | -905.2% |
| HilleVax, Inc. | 51.19 Million USD | -690.702% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -653.675% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4357.483% |
| Immunic, Inc. | 1.33 Million USD | -30243.628% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -11938.555% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -100342.68% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4357.483% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -18846.579% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2319.365% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -18727.163% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 9.049% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -139652.73% |
| bluebird bio, Inc. | 330.32 Million USD | -22.541% |
| DBV Technologies S.A. | 14.38 Million USD | -2714.714% |
| Compugen Ltd. | 1.35 Million USD | -29861.806% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -3675.334% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -16078.417% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -6420.361% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -23894.309% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -846.509% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -8616.279% |
| Benitec Biopharma Inc. | 284 Thousand USD | -142429.577% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -378.723% |
| Adicet Bio, Inc. | 20.92 Million USD | -1834.544% |
| Prime Medicine, Inc. | 13.63 Million USD | -2869.148% |
| Aditxt, Inc. | 18.21 Million USD | -2121.892% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -245.399% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2545.128% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -49972.118% |
| PolyPid Ltd. | 11.77 Million USD | -3336.489% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -342.59% |
| Invivyd, Inc. | 2.16 Million USD | -18596.721% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -11487272.756% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -568.192% |
| CorMedix Inc. | 667.63 Thousand USD | -60529.808% |
| Instil Bio, Inc. | 86.05 Million USD | -370.384% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -698.832% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -109.524% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1243.637% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -7202.616% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2948.991% |
| AbCellera Biologics Inc. | 77.38 Million USD | -423.112% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -385.417% |
| Surrozen, Inc. | 3.37 Million USD | -11879.402% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1549.352% |
| Verona Pharma plc | 51.32 Million USD | -688.607% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -67028.358% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -225.023% |
| Evaxion Biotech A/S | 10.86 Million USD | -3623.974% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -440.382% |
| Shattuck Labs, Inc. | 4.2 Million USD | -9533.127% |
| AlloVir, Inc. | 27.42 Million USD | -1375.752% |
| BioVie Inc. | 6.11 Million USD | -6523.374% |
| Codexis, Inc. | 22.36 Million USD | -1709.98% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -44578.146% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -246769.187% |
| Agenus Inc. | 350.24 Million USD | -15.571% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -180365.448% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -172537.128% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1823.147% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1981.687% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -980.972% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -18735.924% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1320.943% |
| IN8bio, Inc. | 4.89 Million USD | -8172.716% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -30152.915% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -281.641% |
| Liquidia Corporation | 3.5 Million USD | -11455.353% |
| Quantum-Si incorporated | 15.3 Million USD | -2545.128% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -495472.968% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3612.593% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -24387.84% |
| United Therapeutics Corporation | 700 Million USD | 42.174% |
| Solid Biosciences Inc. | 26.26 Million USD | -1441.154% |
| Immuneering Corporation | 4.46 Million USD | -8969.857% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2948.991% |
| uniQure N.V. | 138.4 Million USD | -192.455% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3433.071% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -373.858% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -85117.684% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2946.696% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -192206.486% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2654.57% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -147631.387% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1243.146% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -40994.822% |
| Immunome, Inc. | 1.65 Million USD | -24432.364% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -23257.415% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4039.742% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1239.934% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -111718.785% |
| Altimmune, Inc. | 671 Thousand USD | -60225.484% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -681.814% |
| Rallybio Corporation | 392 Thousand USD | -103161.224% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -9581.512% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -69093.846% |
| Moolec Science SA | 2.64 Million USD | -15202.071% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -97438.313% |
| NeurAxis, Inc. | 224.26 Thousand USD | -180397.637% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 33.747% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6047.062% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4039.742% |
| 180 Life Sciences Corp. | 1.32 Million USD | -30563.852% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1931.946% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2269.913% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -25931.125% |
| Nutriband Inc. | 241.28 Thousand USD | -167661.775% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -48905.327% |
| argenx SE | 20 Million USD | -1923.92% |
| Neurogene Inc. | 16.25 Million USD | -2390.212% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -31.363% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1318.254% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -2172.28% |
| Design Therapeutics, Inc. | 3.05 Million USD | -13171.607% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -154397.71% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2744.982% |
| Achilles Therapeutics plc | 4.61 Million USD | -8671.051% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -284959.155% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3863.419% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -8.312% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1244.842% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -10846.422% |
| Palisade Bio, Inc. | 369 Thousand USD | -109597.561% |
| Beam Therapeutics Inc. | 173.17 Million USD | -133.745% |
| AEON Biopharma, Inc. | 278 Thousand USD | -145505.755% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -120731.045% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -378588.571% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -433.579% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -562.418% |
| Athira Pharma, Inc. | 1.58 Million USD | -25438.423% |
| Vaccinex, Inc. | 247 Thousand USD | -163780.162% |
| HCW Biologics Inc. | 6.45 Million USD | -6173.992% |
| XOMA Corporation | 124.45 Million USD | -225.258% |
| Nektar Therapeutics | 230.4 Million USD | -75.687% |
| Arvinas, Inc. | 3.4 Million USD | -11805.412% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -24707.121% |
| Merus N.V. | 12.16 Million USD | -3228.268% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -215.184% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2830.245% |
| Rezolute, Inc. | 2.22 Million USD | -18068.043% |
| Clene Inc. | 32.16 Million USD | -1158.618% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -231135.112% |
| BeyondSpring Inc. | 3.99 Million USD | -10032.265% |
| Synlogic, Inc. | 17.27 Million USD | -2243.178% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -31037.231% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1156425.714% |
| Peak Bio, Inc. | 10.72 Million USD | -3675.334% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -679.585% |
| Krystal Biotech, Inc. | 8.09 Million USD | -4901.038% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -128.671% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -5635.922% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -296240.981% |
| MannKind Corporation | 382.37 Million USD | -5.859% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3669.641% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -98869.193% |
| Gossamer Bio, Inc. | 212.46 Million USD | -90.519% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -232534.483% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4318.557% |
| Legend Biotech Corporation | 328.67 Million USD | -23.157% |
| Mural Oncology plc | 15 Million USD | -2596.942% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -753.507% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -19166.254% |
| Champions Oncology, Inc. | 7.43 Million USD | -5347.968% |
| REGENXBIO Inc. | 89.29 Million USD | -353.336% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -47259.942% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -73100.213% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -7376.616% |
| Vaxart, Inc. | 26.51 Million USD | -1426.68% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2485.263% |
| Cellectis S.A. | 92.85 Million USD | -335.941% |
| Longeveron Inc. | 2.04 Million USD | -19732.631% |
| Repare Therapeutics Inc. | 3.41 Million USD | -11770.499% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 71.021% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -768.784% |
| Revolution Medicines, Inc. | 87.94 Million USD | -360.275% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -233879.191% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -10139.919% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -127592.114% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -231205.143% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 49.928% |
| Denali Therapeutics Inc. | 52.24 Million USD | -674.84% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2709.934% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -29360.262% |
| Cingulate Inc. | 3.13 Million USD | -12811.363% |
| Passage Bio, Inc. | 26.29 Million USD | -1439.454% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -5973.278% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -99111.765% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -45177.852% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -360.275% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1868.698% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -32025.714% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -16414.24% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -12861.383% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -49811.714% |
| OmniAb, Inc. | 25.56 Million USD | -1483.6% |
| Anew Medical, Inc. | 1.6 Million USD | -25120.187% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1268.306% |
| Lipocine Inc. | 17.16 Thousand USD | -2357956.624% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3378.123% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1068.95% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6752.547% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -607.999% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -199300.985% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -7737.057% |
| Ocugen, Inc. | 6.94 Million USD | -5731.782% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2764.916% |
| Q32 Bio Inc. | 1.31 Million USD | -30611.988% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -60135.714% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1142.431% |
| Equillium, Inc. | 824 Thousand USD | -49024.272% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4358.465% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -134466.465% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -165.782% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -691.552% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -52126.959% |
| Dominari Holdings Inc. | 3.02 Million USD | -13268.032% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -428301.791% |
| vTv Therapeutics Inc. | 529 Thousand USD | -76418.715% |
| Bio-Techne Corporation | 419.53 Million USD | 3.517% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -462.231% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -109.119% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2296.874% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1678.332% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -6581.809% |
| Nkarta, Inc. | 88.33 Million USD | -358.217% |
| BioCardia, Inc. | 1.31 Million USD | -30682.053% |
| Iterum Therapeutics plc | 19.5 Million USD | -1974.858% |